These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23044444)

  • 1. Implementation and community involvement in DOTS strategy: a systematic review of studies in China.
    Hou WL; Song FJ; Zhang NX; Dong XX; Cao SY; Yin XX; Liu JN; Lu ZX
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1433-40. PubMed ID: 23044444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to treatment and supervision for tuberculosis in a DOTS programme among pastoralists in Uganda.
    Kisambu J; Nuwaha F; Sekandi JN
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):799-803. PubMed ID: 24902555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated review of directly observed therapy for tuberculosis in Latin America.
    Zuñiga JA
    Hisp Health Care Int; 2015; 13(1):46-54. PubMed ID: 25741933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia.
    Kibuule D; Rennie TW; Ruswa N; Mavhunga F; Thomas A; Amutenya R; Law MR; Günther G; Ette E; Godman B; Verbeeck RK
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):441-449. PubMed ID: 31064623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy.
    McLaren ZM; Milliken AA; Meyer AJ; Sharp AR
    BMC Infect Dis; 2016 Oct; 16(1):537. PubMed ID: 27716104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China: a case control study.
    Ai X; Men K; Guo L; Zhang T; Zhao Y; Sun X; Zhang H; He G; van der Werf MJ; van den Hof S
    BMC Public Health; 2010 Mar; 10():112. PubMed ID: 20205941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An attempt to reproduce a previous meta-analysis and a new analysis regarding the impact of directly observed therapy on tuberculosis treatment outcomes.
    McKay B; Castellanos M; Ebell M; Whalen CC; Handel A
    PLoS One; 2019; 14(5):e0217219. PubMed ID: 31120965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Zhu L; Yang YZ; Guan HY; Cheng SM; Jin YY; Tan WG; Wu QF; Liu XL; Zhao MG; Lu ZH; Jia ZW
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):759-765. PubMed ID: 28633700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to improve adherence to tuberculosis treatment: systematic review and meta-analysis.
    Müller AM; Osório CS; Silva DR; Sbruzzi G; de Tarso P; Dalcin R
    Int J Tuberc Lung Dis; 2018 Jul; 22(7):731-740. PubMed ID: 29914598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis deaths averted by implementation of the DOTS strategy in Kazakhstan.
    Favorov M; Belilovsky E; Aitmagambetova I; Ismailov S; White ME; Chorba T
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1582-8. PubMed ID: 21144244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of DOTS in tuberculosis treatment and control.
    Davies PD
    Am J Respir Med; 2003; 2(3):203-9. PubMed ID: 14720002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining interventions that aim to enhance TB treatment adherence in Southeast Asia: A systematic review and meta-analysis.
    Davis RA; Leavitt HB; Singh A; Fanouraki E; Yen RW; Bratches RW
    Indian J Tuberc; 2024 Jan; 71(1):48-63. PubMed ID: 38296391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct observation and completion of treatment of tuberculosis in rural areas of China.
    Jianming Wang ; Hongbinh Shen
    Scand J Public Health; 2009 May; 37(3):304-9. PubMed ID: 19286750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bracelet- and self-directed observational therapy for control of tuberculosis: study protocol for a cluster randomized controlled trial.
    Huang R; Ren G; Hu J
    Trials; 2017 Jul; 18(1):286. PubMed ID: 28673323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing management of tuberculosis treatment with video directly observed therapy in New York City.
    Chuck C; Robinson E; Macaraig M; Alexander M; Burzynski J
    Int J Tuberc Lung Dis; 2016 May; 20(5):588-93. PubMed ID: 27084810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India.
    Negandhi H; Tiwari R; Sharma A; Nair R; Zodpey S; Reddy Allam R; Oruganti G
    Glob Health Action; 2017; 10(1):1290315. PubMed ID: 28485693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial.
    Newell JN; Baral SC; Pande SB; Bam DS; Malla P
    Lancet; 2006 Mar; 367(9514):903-9. PubMed ID: 16546538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China.
    Hu Y; Mathema B; Wang W; Hoffner S; Kreiswirth B; Xu B
    Microb Drug Resist; 2008 Sep; 14(3):227-32. PubMed ID: 18707239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.